The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | MWH SOLV Energy, Inc. | American Securities LLC owner | CConversion Class A Common Stockindirect: See Notes | +3,069,193 | - | - | 85,989,594 | Aug 21, 2026 |
| Aug 19, 2026 | MWH SOLV Energy, Inc. | American Securities LLC owner | CConversion SOLV Energy Holdings LLC Interestsderivativeindirect: See Notes | -3,069,193 | - | - | 49,189,706 | Aug 21, 2026 |
| Aug 19, 2026 | MWH SOLV Energy, Inc. | American Securities LLC owner | CConversion Class A Common Stockindirect: See Notes | +3,069,193 | - | - | 85,989,594 | Aug 21, 2026 |
| Aug 19, 2026 | MWH SOLV Energy, Inc. | American Securities LLC owner | CConversion SOLV Energy Holdings LLC Interestsderivativeindirect: See Notes | -3,069,193 | - | - | 49,189,706 | Aug 21, 2026 |
| Aug 19, 2026 | ABNB Airbnb, Inc. | Nathan Blecharczyk Chief Strategy Officer | CConversion Class A Common Stockindirect: By Trust10b5-1 | +450 | - | - | 20,567 | Aug 21, 2026 |
| Aug 19, 2026 | ABNB Airbnb, Inc. | Nathan Blecharczyk Chief Strategy Officer | CConversion Class B Common Stockderivativeindirect: By Trust10b5-1 | -450 | $0.00 | $0 | 45,008,659 | Aug 21, 2026 |
| Aug 19, 2026 | QS QuantumScape Corp | Timothy Holme CHIEF TECHNOLOGY OFFICER | CConversion Class A Common Stockindirect: By: The Holme 2020 Irrevocable Trust10b5-1 | +21,531 | $0.00 | $0 | 21,531 | Aug 20, 2026 |
| Aug 19, 2026 | QS QuantumScape Corp | Timothy Holme CHIEF TECHNOLOGY OFFICER | CConversion Class B Common Stockderivativeindirect: By: The Holme 2020 Irrevocable Trust10b5-1 | -21,531 | $0.00 | $0 | 1,225,080 | Aug 20, 2026 |
| Aug 18, 2026 | CRWV CoreWeave, Inc. | Michael N Intrator CEO and President | CConversion Class A Common Stockindirect: Omnadora Capital LLC10b5-1 | +107,692 | - | - | 107,692 | Aug 20, 2026 |
| Aug 18, 2026 | CRWV CoreWeave, Inc. | Michael N Intrator CEO and President | CConversion Class B Common Stockderivativeindirect: Omnadora Capital LLC10b5-1 | -107,692 | - | - | 22,695,432 | Aug 20, 2026 |
| Aug 18, 2026 | CBRS Cerebras Systems Inc. | Robert Patrick Komin Jr. Chief Financial Officer | CConversion Class A Common Stock | +32,500 | $0.00 | $0 | 32,500 | Aug 20, 2026 |
| Aug 18, 2026 | CBRS Cerebras Systems Inc. | Robert Patrick Komin Jr. Chief Financial Officer | CConversion Class B Common Stockderivative | -32,500 | - | - | 821,653 | Aug 20, 2026 |
| Aug 18, 2026 | CBRS Cerebras Systems Inc. | Yagnesh Patel Chief Accounting Officer | CConversion Class A Common Stock | +6,250 | - | - | 21,250 | Aug 20, 2026 |
| Aug 18, 2026 | CBRS Cerebras Systems Inc. | Yagnesh Patel Chief Accounting Officer | CConversion Class B Common Stockderivative | -6,250 | - | - | 114,588 | Aug 20, 2026 |
| Aug 18, 2026 | CBRS Cerebras Systems Inc. | Dhiraj Mallick Chief Operating Officer | CConversion Class A Common Stock | +158,889 | - | - | 158,889 | Aug 20, 2026 |
| Aug 18, 2026 | CBRS Cerebras Systems Inc. | Dhiraj Mallick Chief Operating Officer | CConversion Class B Common Stockderivative | -158,889 | $0.00 | $0 | 520,807 | Aug 20, 2026 |
| Aug 18, 2026 | CBRS Cerebras Systems Inc. | Sean Lie Chief Technology Officer | CConversion Class A Common Stock | +616,706 | - | - | 616,706 | Aug 20, 2026 |
| Aug 18, 2026 | CBRS Cerebras Systems Inc. | Sean Lie Chief Technology Officer | CConversion Class B Common Stockderivative | -616,706 | - | - | 7,582,992 | Aug 20, 2026 |
| Aug 18, 2026 | CBRS Cerebras Systems Inc. | Steven Vassallo director | CConversion Class A Common Stockindirect: By Foundation Capital VIII, L.P. | +1,738,913 | - | - | 1,738,913 | Aug 20, 2026 |
| Aug 18, 2026 | CBRS Cerebras Systems Inc. | Steven Vassallo director | CConversion Class A Common Stockindirect: By Foundation Capital VIII Principals Fund, L.L.C. | +37,453 | - | - | 37,453 | Aug 20, 2026 |
| Aug 18, 2026 | CBRS Cerebras Systems Inc. | Steven Vassallo director | CConversion Class A Common Stockindirect: By Foundation Capital Leadership Fund II, L.P. | +136,426 | - | - | 136,426 | Aug 20, 2026 |
| Aug 18, 2026 | CBRS Cerebras Systems Inc. | Steven Vassallo director | CConversion Class B Common Stockderivativeindirect: By Foundation Capital VIII, L.P. | -1,738,913 | - | - | 10,433,479 | Aug 20, 2026 |
| Aug 18, 2026 | CBRS Cerebras Systems Inc. | Steven Vassallo director | CConversion Class B Common Stockderivativeindirect: By Foundation Capital VIII Principals Fund, LLC | -37,453 | - | - | 224,721 | Aug 20, 2026 |
| Aug 18, 2026 | CBRS Cerebras Systems Inc. | Steven Vassallo director | CConversion Class B Common Stockderivativeindirect: By Foundation Capital Leadership Fund II, L.P. | -136,426 | - | - | 818,559 | Aug 20, 2026 |
| Aug 18, 2026 | CBRS Cerebras Systems Inc. | Foundation Capital Management Co. VIII, L.L.C. owner | CConversion Class A Common Stockindirect: By Foundation Capital VIII, L.P. | +1,738,913 | - | - | 1,738,913 | Aug 20, 2026 |
| Aug 18, 2026 | CBRS Cerebras Systems Inc. | Foundation Capital Management Co. VIII, L.L.C. owner | CConversion Class A Common Stockindirect: By Foundation Capital VIII Principals Fund, L.L.C. | +37,453 | - | - | 37,453 | Aug 20, 2026 |
| Aug 18, 2026 | CBRS Cerebras Systems Inc. | Foundation Capital Management Co. VIII, L.L.C. owner | CConversion Class A Common Stockindirect: By Foundation Capital Leadership Fund II, L.P. | +136,426 | - | - | 136,426 | Aug 20, 2026 |
| Aug 18, 2026 | CBRS Cerebras Systems Inc. | Foundation Capital Management Co. VIII, L.L.C. owner | CConversion Class B Common Stockderivativeindirect: By Foundation Capital VIII, L.P. | -1,738,913 | - | - | 10,433,479 | Aug 20, 2026 |
| Aug 18, 2026 | CBRS Cerebras Systems Inc. | Foundation Capital Management Co. VIII, L.L.C. owner | CConversion Class B Common Stockderivativeindirect: By Foundation Capital VIII Principals Fund, LLC | -37,453 | - | - | 224,721 | Aug 20, 2026 |
| Aug 18, 2026 | CBRS Cerebras Systems Inc. | Foundation Capital Management Co. VIII, L.L.C. owner | CConversion Class B Common Stockderivativeindirect: By Foundation Capital Leadership Fund II, L.P. | -136,426 | - | - | 818,559 | Aug 20, 2026 |
| Aug 18, 2026 | IMAX IMAX CORP | Richard L Gelfond Chief Executive Officer | CConversion common shares10b5-1 | +151,253 | $31.90 | $4.8M | 916,255 | Aug 20, 2026 |
| Aug 19, 2026 | IMAX IMAX CORP | Richard L Gelfond Chief Executive Officer | CConversion common shares10b5-1 | +205,504 | $31.90 | $6.6M | 970,506 | Aug 20, 2026 |
| Aug 18, 2026 | IMAX IMAX CORP | Richard L Gelfond Chief Executive Officer | CConversion stock options (to buy)derivative10b5-1 | -151,253 | $31.90 | $4.8M | 1,181,158 | Aug 20, 2026 |
| Aug 19, 2026 | IMAX IMAX CORP | Richard L Gelfond Chief Executive Officer | CConversion stock options (to buy)derivative10b5-1 | -205,504 | $31.90 | $6.6M | 975,654 | Aug 20, 2026 |
| Jul 9, 2026 | PLMK Plum Acquisition Corp, IV | Avanish Sahai director | CConversion Class A ordinary sharesindirect: See footnote | +25,000 | - | - | 25,000 | Aug 20, 2026 |
| Jul 9, 2026 | PLMK Plum Acquisition Corp, IV | Avanish Sahai director | CConversion Class B ordinary sharesderivativeindirect: See footnote | -25,000 | $0.00 | $0 | 0 | Aug 20, 2026 |
| Jul 9, 2026 | PLMK Plum Acquisition Corp, IV | Anjai Gandhi director | CConversion Class A ordinary sharesindirect: See footnote | +25,000 | - | - | 25,000 | Aug 20, 2026 |
| Jul 9, 2026 | PLMK Plum Acquisition Corp, IV | Anjai Gandhi director | CConversion Class B ordinary sharesderivativeindirect: See footnote | -25,000 | $0.00 | $0 | 0 | Aug 20, 2026 |
| Jul 9, 2026 | PLMK Plum Acquisition Corp, IV | Allan Chou director | CConversion Class A ordinary shares | +25,000 | - | - | 25,000 | Aug 20, 2026 |
| Jul 9, 2026 | PLMK Plum Acquisition Corp, IV | Allan Chou director | CConversion Class B ordinary sharesderivative | -25,000 | $0.00 | $0 | 0 | Aug 20, 2026 |
| Aug 18, 2026 | GPCR Structure Therapeutics Inc. | Xichen Lin CHIEF SCIENTIFIC OFFICER | CConversion Ordinary Shares10b5-1 | -11,817 | $0.00 | $0 | 228,960 | Aug 19, 2026 |
| Aug 18, 2026 | GPCR Structure Therapeutics Inc. | Xichen Lin CHIEF SCIENTIFIC OFFICER | CConversion American Depositary Sharesderivative10b5-1 | +3,939 | $0.00 | $0 | 3,939 | Aug 19, 2026 |
| Aug 19, 2026 | CRCT Cricut, Inc. | Arora Ashish Chief Executive Officer | CConversion Class A Common Stock10b5-1 | +1,750,000 | - | - | 5,777,105 | Aug 19, 2026 |
| Aug 19, 2026 | CRCT Cricut, Inc. | Arora Ashish Chief Executive Officer | CConversion Class B Common Stockderivative10b5-1 | -1,750,000 | $0.00 | $0 | 20,257,506 | Aug 19, 2026 |
| Aug 17, 2026 | CRWV CoreWeave, Inc. | Brannin McBee Chief Development Officer | CConversion Class A Common Stockindirect: Canis Major 2024 Irrevocable Trust LLC10b5-1 | +3,000 | - | - | 3,000 | Aug 19, 2026 |
| Aug 17, 2026 | CRWV CoreWeave, Inc. | Brannin McBee Chief Development Officer | CConversion Class A Common Stockindirect: Canis Major 2025 GRAT10b5-1 | +40,000 | - | - | 40,000 | Aug 19, 2026 |
| Aug 17, 2026 | CRWV CoreWeave, Inc. | Brannin McBee Chief Development Officer | CConversion Class A Common Stockindirect: Canis Minor 2025 GRAT10b5-1 | +12,500 | - | - | 12,500 | Aug 19, 2026 |
| Aug 17, 2026 | CRWV CoreWeave, Inc. | Brannin McBee Chief Development Officer | CConversion Class B Common Stockderivativeindirect: Canis Major 2024 Irrevocable Trust LLC10b5-1 | -3,000 | - | - | 291,000 | Aug 19, 2026 |
| Aug 17, 2026 | CRWV CoreWeave, Inc. | Brannin McBee Chief Development Officer | CConversion Class B Common Stockderivativeindirect: Canis Major 2025 GRAT10b5-1 | -40,000 | - | - | 3,477,227 | Aug 19, 2026 |
| Aug 17, 2026 | CRWV CoreWeave, Inc. | Brannin McBee Chief Development Officer | CConversion Class B Common Stockderivativeindirect: Canis Minor 2025 GRAT10b5-1 | -12,500 | - | - | 423,705 | Aug 19, 2026 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.